These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6020454)

  • 1. On the isolation and characterization of substances in the urine of patients with collagen disease.
    Nishimura MORI Y; Matsunaka M; Matoba S; Kawasaki H; Yamaguchi M; Matsukawa S
    J Chronic Dis; 1967 Feb; 20(2):55-8. PubMed ID: 6020454
    [No Abstract]   [Full Text] [Related]  

  • 2. Unidentified urinary compounds, f2 and f4'.
    Ura A; Nishimura N; Yamaguchi M
    Wakayama Med Rep; 1969 Sep; 13(4):163-8. PubMed ID: 5384437
    [No Abstract]   [Full Text] [Related]  

  • 3. [Method for the determination of 2,5-dihydroxyphenylpyruvic acid in the urine].
    Sobĕslavský C; Hladíková D
    Cas Lek Cesk; 1968 May; 107(20):607-10. PubMed ID: 5664841
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary free proline and collagen metabolites in newborns, healthy children, and in collagen diseases.
    Danelatos-Athanassiadis ; Constantsas NS; Agathopoulos AS; Matsaniotis NS
    Clin Chim Acta; 1969 Jan; 23(1):153-64. PubMed ID: 5762124
    [No Abstract]   [Full Text] [Related]  

  • 5. [2,5-Dihydroxypyruvic acid in the urine of patients with various collagen diseases].
    GONNARD P; LEGRAND JC; GRUPPER C
    Bull Soc Fr Dermatol Syphiligr; 1959; 4():510-4. PubMed ID: 13850963
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism of aromatic amino acids in collagen diseases: urinary excretion of 3-methoxy-4-hydroxymandelic acid and the interference of 3-methoxy-4-hydroxyphenylpyruvate.
    Choremis KB; Constantsas NS; Agathopoulos AS; Matsaniotis N; Danelatos-Athanassiadis C
    Clin Chim Acta; 1967 Jul; 17(1):125-30. PubMed ID: 4292086
    [No Abstract]   [Full Text] [Related]  

  • 7. [Urinary corticoids in some collagen diseases and in various allergic diseases].
    ROSKAM J; VAN CAUWENBERGE H
    Acta Med Scand Suppl; 1956; 312():337-50. PubMed ID: 13339201
    [No Abstract]   [Full Text] [Related]  

  • 8. 2,5-Dihydroxyphenylpyruvic acid and collagen diseases.
    TYE MJ; MASTERS S; APPEL B; WHITE H; TANAKA T KNOX WE; CULLEN A; ROSEN B
    Arch Dermatol; 1960 Mar; 81():447-52. PubMed ID: 13840083
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenylalanine and tyrosine in collagen diseases. Urinary excretion of general intermediary metabolites of tyrosine in patients with collagen disease and liver disease.
    NISHIMURA N; MAEDA K; YASUI M; OKAMOTO H; MATSUNAKA M; TOSHINA H
    Arch Dermatol; 1961 Apr; 83():644-52. PubMed ID: 13729226
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolism of aromatic amino acids in collagen diseases. Urinary excretion of metanephrine and normetanephrine, and spontaneous degradation of vanilpyruvic acid.
    Choremis KB; Agathopoulos AS; Constantsas NS; Danelatos-Athanassiadis C
    Clin Chim Acta; 1966 May; 13(5):574-81. PubMed ID: 5962916
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of mucoproteins in urine in collagen diseases, endocrine diseases and hormone therapy].
    ALBEAUX-FERNET M; BUGARD P; ROMANI JD
    Presse Med (1893); 1955 Apr; 63(25):509-11. PubMed ID: 14384724
    [No Abstract]   [Full Text] [Related]  

  • 12. 2,5-Dihydroxyphenyl-pyruvic acid in human urine. Preliminary identification.
    YEE HY; McCANN DS; KEECH MK; DENKO CW; BOYLE AJ
    Arch Dermatol; 1961 Aug; 84():293-301. PubMed ID: 13787288
    [No Abstract]   [Full Text] [Related]  

  • 13. [Determination of urinary corticoids].
    JAKOBSON T
    Duodecim; 1952; 68(11):972-83. PubMed ID: 13033769
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on acid mucopolysaccharides in the urine. II. In collagen diseases].
    Kamikubo K
    Nihon Shonika Gakkai Zasshi; 1966 Apr; 70(4):302-8. PubMed ID: 4224598
    [No Abstract]   [Full Text] [Related]  

  • 15. [Copper ion-binding substances in urine of patients with rheumatoid arthritis].
    Krzymień H
    Pol Tyg Lek; 1971 Nov; 26(45):1740-2. PubMed ID: 5133692
    [No Abstract]   [Full Text] [Related]  

  • 16. [Research on urinary elimination of reducing substances in the first and second infancy: comparison of results obtained with paper and thin layer chromatography].
    Giovannini M; Consonni V; Calleri A
    Minerva Pediatr; 1965 Oct; 17(32):1702-3. PubMed ID: 5860430
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of the secretion of 2,5 dihydroxyphenylpyruvic acid in collagen diseases].
    Hladíková D; Sobĕslavský C; Susta A; Havelka S
    Fysiatr Revmatol Vestn; 1968 Jul; 46(4):201-9. PubMed ID: 5691511
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the excretion of acid mucopolysaccharides in urine. I. Methodology and normal values].
    Delbrück A; Grimme H; Wette K
    Z Klin Chem Klin Biochem; 1967 Jan; 5(1):10-21. PubMed ID: 4233181
    [No Abstract]   [Full Text] [Related]  

  • 19. On the specificity of pyrrole-1,2-dicarboimide for collagen diseases.
    Yamaguchi M; Matsukawa S; Ura A; Koyama M; Imura T
    Wakayama Med Rep; 1969 Sep; 13(4):169-71. PubMed ID: 5384438
    [No Abstract]   [Full Text] [Related]  

  • 20. The response of patients with collagen diseases to an acid load.
    Cheng JT
    Nihon Jinzo Gakkai Shi; 1975 Aug; 17(8):715. PubMed ID: 4638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.